Loading...
ROCO
6496
Market cap36mUSD
Jul 09, Last price  
25.35TWD
1D
1.81%
1Q
-4.88%
Jan 2017
-59.76%
IPO
-62.99%
Name

Excelsior Biopharma Inc

Chart & Performance

D1W1MN
ROCO:6496 chart
P/E
P/S
1.32
EPS
Div Yield, %
Shrs. gr., 5y
-1.30%
Rev. gr., 5y
-9.05%
Revenues
898m
+4.22%
1,540,064,0001,443,661,0001,338,392,000671,763,000771,562,000861,911,000898,263,000
Net income
-183m
L+85.57%
71,012,00035,300,000-15,649,000-33,757,000-91,011,000-98,705,000-183,169,000
CFO
-139m
L+39.01%
0520,813,99955,823,0005,486,000-134,750,000-99,797,000-138,723,000
Dividend
Jul 13, 20211 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei, Taiwan, functions as a pharmaceutical enterprise with a global market presence, encompassing Taiwan, China, and other international regions. The company offers a comprehensive range of healthcare solutions, including prescription and over-the-counter medications, medical devices, nutritional supplements, and various medical supplies. Excelsior addresses numerous therapeutic areas such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, otorhinolaryngology, and infectious disease management. Its product line also features specialized diagnostic kits under the Actim brand for identifying conditions like influenza virus, fecal occult blood, acute pancreatitis, and for assessing preterm or full-week delivery and early membrane rupture. Moreover, the company provides oral hygiene products, including toothpaste, mouthwash, and gels, under the Oral7 name. Beyond product sales, Excelsior is involved in the import and export of active pharmaceutical ingredients, as well as engaging in technological research, facilitating pharmaceutical technology transfer, and participating in collaborative development and improvement initiatives. The company adopted its current name, Excelsior Biopharma Inc., in June 2003, having previously been known as Excelsior Enterprise Co., Ltd.
IPO date
Dec 19, 2014
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT